5 results match your criteria: "Department of University Cardiac Surgery[Affiliation]"
Surgical management of traumatic tricuspid regurgitation: a case report.
Eur Heart J Case Rep
January 2025
Department of Cardiac Surgery, Medical University Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Background: Traumatic tricuspid valve regurgitation is a rare condition related to blunt chest trauma. In the early phase, the patients may remain asymptomatic. Progressive tricuspid regurgitation leads to the development of symptoms thereafter.
View Article and Find Full Text PDFConflicts of interest in clinical practice: lessons learned from cardiovascular medicine.
Eur J Cardiothorac Surg
September 2024
Cardiology and Cardiovascular Surgery Discipline, Centro Universitário Fundação Assis Gurgacz, Cascavel, Brazil.
Article Synopsis
- Cardiovascular diseases are a big problem around the world, and clinical trials help find better treatments for them.
- Conflicts of interest (COIs), which can happen when companies have a say in research, can affect how trials are carried out and the results they show.
- It's important to be careful about COIs in studies because they can change guidelines that doctors follow, and sharing rules and being open about research can help keep everyone’s trust in the science.
Risk of Bias in Randomized Clinical Trials Comparing Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysis.
JAMA Netw Open
January 2023
Department of University Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.
Article Synopsis
- Recent guidelines from European cardiology organizations raised concerns about biases in RCTs comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) for aortic stenosis, highlighting the need to evaluate these biases quantitatively.
- The study aimed to determine if randomization in RCTs effectively protects against biases beyond nonrandom allocation, using a systematic literature review from January 2007 to June 2022.
- Out of 8 eligible trials with nearly 8,849 participants, results indicated a 4.2% rate of deviation from assigned treatment (DAT), showing TAVI had a significantly lower risk of DAT compared to SAVR, suggesting potential advantages in treatment
The 2021 American College of Cardiology/American Heart Association/Society for Cardiac Angiography and Interventions guideline for coronary artery revascularization. A worldwide call for consistency and logic.
J Thorac Cardiovasc Surg
January 2023
Department of Cardiac Surgery, University Hospital of Navarra, Pamplona, Spain.
Cardiac surgery practice during the COVID-19 outbreak: a multicentre national survey.
Eur J Cardiothorac Surg
April 2021
Department of Translational Medicine, Cardiac Surgery Unit, University of Campania, Luigi Vanvitelli, AORN dei Colli, Cardiac Surgery, Vincenzo Monaldi Hospital, Naples, Italy.
Objectives: Healthcare systems worldwide have been overburdened by the coronavirus disease 2019 (COVID-19) outbreak. Accordingly, hospitals had to implement strategies to profoundly reshape both non-COVID-19 medical care and surgical activities. Knowledge about the impact of the COVID-19 pandemic on cardiac surgery practice is pivotal.
View Article and Find Full Text PDF